
Richard A. Van Etten MD PhD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Professor of Medicine, University of California Irvine; Director, Chao Family Comprehensive Cancer Center
Join to View Full Profile
101 The City Dr SOrange, CA 92868
Phone+1 714-456-5153
Fax+1 855-211-3729
Dr. Van Etten is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Van Etten is a hematologist in Orange, CA and is affiliated with UC Irvine Medical Center, where he is the Director of UCI's Chao Family Comprehensive Cancer Center, a comprehensive cancer center designated by the National Cancer Institute. He received his medical degree from Stanford University School of Medicine and has been in practice 33 years. He specializes in hematologic oncology and myeloproliferative disorders and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987
Stanford University School of MedicineClass of 1984
M.I.T.BS, Biology and Mathematics, 1974 - 1978
Certifications & Licensure
CA State Medical License 2013 - 2027
MA State Medical License 1986 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 3 citationsInterrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.Tariq I. Mughal, Bethan Psaila, Daniel J. DeAngelo, Giuseppe Saglio, Richard A. Van Etten
Haematologica. 2021-03-04 - 6 citationsOptimal experimental design for mathematical models of haematopoiesis.Luis Martinez Lomeli, Abdon Iniguez, Prasanthi Tata, Nilamani Jena, Zhong-Ying Liu
Journal of the Royal Society, Interface. 2021-01-27 - 3 citationsIlluminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.Tariq I. Mughal, Naveen Pemmaraju, Bethan Psaila, Jerald P. Radich, Prithviraj Bose
Hematological Oncology. 2020-06-27
Press Mentions
Unique Pan-Cancer Immunotherapy Destroys Tumors Without Attacking Healthy Tissue, UC Irvine Study ShowsSeptember 26th, 2025
Innovative Pan-Cancer Immunotherapy Targets Tumors While Sparing Healthy Tissue, UC Irvine Study FindsSeptember 25th, 2025
Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024June 10th, 2024
Grant Support
- Mechanisms of treatment-free remission in a mouse model of chronic myeloid leukemiaUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
- Cancer Center Support GrantUNIVERSITY OF CALIFORNIA-IRVINE1997–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









